ACB Stock Down as Q1 Earnings Miss Estimates, Revenues Up Y/Y
Shares of this company lost nearly 6.1% in today's pre-market hours. The company's shares have gained 8.2% in the year-to-date period compared with the industry's growth of 4.6%. The broader S&P 500 Index has increased 6.9% in the same time frame.
Aurora Cannabis Revenue Details
The company reported total net revenues of $98 million, up 17.5% year over year. The top line beat the Zacks Consensus Estimate by 38.3%.
Revenues were driven by strong momentum in international medical cannabis markets, with higher sales to Australia, Germany, Poland, and the United Kingdom. The company also saw increased revenues in Canada, supported by insurance-covered and self-paying patients. This strategic emphasis on high-margin medical sales helped offset continued declines in the consumer cannabis segment, while modest gains in the plant propagation business added further support.
Image Source: Zacks Investment Research
Segmental Details
Global Medical Cannabis
Aurora Cannabis' Global Medical Cannabis segment delivered $64.8 million in revenues, up 37% year over year, and continued to be the company's strongest contributor. This growth was fueled by rising demand across both international and domestic markets.
International Medical Cannabis
International Medical Cannabis revenues surged 84.7% year over year to $37.1 million, driven by higher sales in Australia, Germany, Poland, and the UK. Aurora Cannabis leveraged its regulatory expertise, GMP-certified facilities, and global supply chain to meet increasing patient needs in these key export markets.
Canadian Medical Cannabis
The Canadian sub-segment generated $27.7 million in revenues, up 2.1% year over year. Growth was supported by increased purchasing from insurance-covered and self-paying patients. The steady domestic demand, combined with operational efficiency, contributed to maintaining the segment's strong margin profile.
Consumer Cannabis
Consumer cannabis revenue declined 32% year over year to $7.9 million.
The decrease was due to the company's continued decision to prioritize the supply of its GMP-manufactured products to the high-margin global medical cannabis business, rather than the lower-margin consumer segment.
The Wholesale Bulk Cannabis segment recorded $1.43 million in net revenue, up from $0.83 million in the year-ago period.
Plant Propagation
Plant propagation net revenue was wholly comprised of the Bevo business, contributing $23.9 million, up 3.8% from the prior-year period. The increase was a result of organic growth and expanded product offerings, both driven by increased production capacity.
Aurora Cannabis Inc. Price, Consensus and EPS Surprise
Aurora Cannabis Inc. price-consensus-eps-surprise-chart | Aurora Cannabis Inc. Quote
ACB's Margin Trend
In the quarter under review, Aurora Cannabis' gross profit declined 34.9% year over year to $27.9 million. However, the adjusted gross margin expanded 1000 basis points to 52%.
Selling and marketing expenses increased 3.1% year over year to $14.5 million. General and administration expenses increased 25.8% year over year to $28.6 million. Research and development expenses declined 16% year over year to $0.8 million. Total operating expenses of $48.2 million increased 9.7% year over year.
Operating loss for the quarter under review totaled $20.2 million compared with $0.9 million in the prior-year quarter.
Financial Position
ACB exited the first quarter of fiscal 2026 with cash and cash equivalents of $140.2 million compared with $137.9 million at the fiscal 2025-end.
Net cash provided by operating activities at the end of the first quarter was $10.1 million compared with $8.3 million a year ago.
Guidance Update
Aurora Cannabis expects consolidated net revenue to increase year over year in the fiscal second quarter of 2026, with the primary growth driver anticipated to increase in the range of 8%-12% in Global Medical Cannabis revenue.
The Plant Propagation segment is expected to perform in line with traditional seasonal trends, with the company reiterating that 25% to 35% of its annual propagation revenue is typically earned in the second half of the calendar year.
ACB's free cash flow is expected to remain positive on a full-year basis.
Zacks Rank and Stocks to Consider
ACB carries a Zacks Rank #4 (Sell) at present.
Some better-ranked stocks in the broader medical space that have announced quarterly results are Medpace Holdings, Inc. MEDP, West Pharmaceutical Services, Inc. WST and Boston Scientific Corporation BSX.
Medpace Holdings, sporting a Zacks Rank of 1 (Strong Buy), reported second-quarter 2025 EPS of $3.10, beating the Zacks Consensus Estimate by 3.3%. Revenues of $603.3 million outpaced the consensus mark by 11.5%. You can see the complete list of today's Zacks #1 Rank stocks here.
Medpace Holdings has a long-term estimated growth rate of 11.4%. MEDP's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 13.9%.
West Pharmaceutical reported second-quarter 2025 adjusted EPS of $1.84, beating the Zacks Consensus Estimate by 21.9%. Revenues of $766.5 million surpassed the Zacks Consensus Estimate by 5.4%. It currently flaunts a Zacks Rank #1.
West Pharmaceutical has a long-term estimated growth rate of 8.5%. WST's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%.
Boston Scientific reported second-quarter 2025 adjusted EPS of 75 cents, beating the Zacks Consensus Estimate by 4.2%. Revenues of $5.06 billion surpassed the Zacks Consensus Estimate by 3.5%. It currently carries a Zacks Rank #2 (Buy).
Boston Scientific has a long-term estimated growth rate of 14%. BSX's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 8.1%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Boston Scientific Corporation (BSX) : Free Stock Analysis Report
West Pharmaceutical Services, Inc. (WST) : Free Stock Analysis Report
Medpace Holdings, Inc. (MEDP) : Free Stock Analysis Report
Aurora Cannabis Inc. (ACB) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
a few seconds ago
- CNBC
Here are 3 stocks that are working in Thursday's mixed market and another that is not
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Thursday's key moments. 1. Tech stocks rose Thursday on the broad exemptions included in the chip tariffs that President Donald Trump announced after Wednesday's close. Club name Nvidia jumped 2%. Shares of Apple , also in the portfolio, rallied for a second day after unveiling a new $100 billion investment in U.S. manufacturing. Thursday did mark the beginning of so-called reciprocal tariffs for countries without trade deals. The tech-heavy Nasdaq was the big winner so far, while the S & P 500 was on either side of unchanged. 2. Club stock Eli Lilly was having a terrible day after the drugmaker's late-stage trial data on its obesity pill did not show the kind of weight loss that investors had anticipated. The data overshadowed what was an excellent quarter and a full-year guidance boost. Nevertheless, Jim Cramer said that CEO Dave Ricks' tone on the trial data during the conference call also didn't do the stock any favors. We're still debating what to do next with the stock. We did sell some shares of Lilly last week after GLP-1 competitor Novo Nordisk 's quarter disappointed. Our full analysis of the Lilly situation will be sent out later Thursday. Check your inboxes and texts. 3. Costco stock rose modestly after another good month of sales. It also benefited from the general upswing in retail given the expectation that the Federal Reserve will lower interest rates at next month's meeting. After Wednesday's close, Costco said U.S. same-store sales, called comps in the industry, accelerated to 6.5%, when excluding gas sales and currency fluctuations. Jim said he sees Costco stock working its way back to the all-time highs since back in February. 4. Stocks covered in Thursday's rapid fire at the end of the video were e.l.f. Beauty , Dutch Bros , DoorDash , Airbnb , and Fortinet . (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Business Insider
a few seconds ago
- Business Insider
Quant hedge funds start digging out of their hole
Quant hedge funds might have finally seen the light at the end of the tunnel. After weeks of minor losses that one fund executive described as a " long, slow bleed," systematic funds ended July with a strong week, according to a note sent by Morgan Stanley to clients after trading last Thursday. The note stated that July's final week clawed back roughly 30% of quant losses for the month, "softening the blow for what's otherwise been a strong year." A note from Goldman Sachs' prime brokerage unit said stock-picking quants ended July down 2%, bringing the average fund's annual return to less than 10%. This figure still bests the average hedge fund and the S&P 500 over the same timeframe, but the summer slowdown put the brakes on what had been shaping up to be a great year. At London-based Qube Research & Technologies, the fast-growing quant firm fell 4.5% in its flagship fund in July, a person close to the firm told Business Insider, clawing back some losses in the last week of July. The fund is still up more than 13% for the year. Engineers Gate, the $4 billion manager, ended May up 12%, but lost more than 4% in July, a person close to the firm said. Its 2025 returns now sit at 7.1% through July after a strong close to the month. Man Group's multistrategy quant strategy, AHL Dimension, lost more than 3% in July, the firm's website shows. The strategy is down close to 9% on the year. Walleye's quant group was the worst performer of the firm's four strategies in July, the firm told investors in a recent update, but was still positive thanks to Asian strategies offsetting losses in the US. The managers declined to comment. Since the start of June, a combination of factors, including a momentum sell-off and crowded trades, have stung quant managers. Still, many in the industry were anticipating a significant bounce-back once things reverted. "We think strong hands should be levering up into this headwind," a mid-July note from former Bridgewater investment committee member and Dark Forest Technologies founder Jacob Kline read.
Forbes
a few seconds ago
- Forbes
Plug Power: Is Another Post-Earnings Drop For PLUG Stock Inbound?
Plug Power (NASDAQ: PLUG), a company specializing in hydrogen fuel cells, is anticipated to announce its earnings on Monday, August 11, 2025. Historical trends suggest that the stock is more likely to experience a negative one-day reaction. In the past five years, PLUG has recorded a one-day decrease following earnings in 61% of the cases, showing a median loss of -5.9% and a maximum one-day decline of -40.5%. This underscores the stock's considerable volatility around earnings announcements. For traders who react to events, recognizing these historical trends can offer an advantage, though the actual outcomes compared to consensus forecasts will be the main factor influencing actions. Here are two potential strategies to explore: Consensus projections indicate a significant improvement in the company's performance for this quarter. Analysts anticipate revenue of $158 million and an adjusted loss of $0.16 per share, a positive comparison to the same quarter last year, during which revenue stood at $143 million and the adjusted loss was $0.34 per share. From a fundamentals standpoint, the company currently holds a market capitalization of $1.4 billion. In the past twelve months, Plug Power has generated $642 million in revenue but recorded operational losses, with operating losses of -$988 million and a net loss of -$2.0 billion. However, for those seeking potential gains with less volatility compared to individual stocks, the Trefis High Quality portfolio offers an alternative — it has outperformed the S&P 500 and achieved returns exceeding 91% since its launch. In addition, check out – What's Happening With JOBY Stock? View earnings reaction history of all stocks Historical Probability of Positive Post-Earnings Returns for Plug Power Here are some insights into one-day (1D) post-earnings returns: Additional information regarding observed 5-Day (5D) and 21-Day (21D) returns after earnings is summarized along with the statistics in the table below. Related – Plug Power's Hydrogen Hopes Dashed? Correlation Between 1D, 5D, and 21D Historical Returns A relatively less risky strategy (though of limited utility if the correlation is weak) involves understanding the correlation between short-term and medium-term returns post-earnings, identifying a pair that exhibits the highest correlation, and implementing the proper trade. For instance, if 1D and 5D demonstrate the strongest correlation, a trader could opt for a 'long' position for the next 5 days if the 1D post-earnings return is positive. Below is some correlation data based on both a 5-year and a 3-year (more recent) timeline. Note that the correlation 1D_5D refers to the correlation between 1D post-earnings returns and the following 5D returns. Additionally, see – Buy or Sell PLUG Stock? Is There Any Correlation With the Earnings of Peers? At times, the performance of peers can impact the stock reaction following earnings. In fact, the pricing might begin before the earnings announcements are made. Below is some historical data on the post-earnings performance of Plug Power stock in comparison to the stock performance of peers that released their earnings just prior to Plug Power. For a fair comparison, peer stock returns also reflect post-earnings one-day (1D) returns. Discover more about the Trefis RV strategy that has outperformed its all-cap stocks benchmark (a combination of all three, the S&P 500, S&P mid-cap, and Russell 2000), delivering strong returns for investors. Separately, if you seek upside with a smoother experience compared to an individual stock like Plug Power, consider the High Quality portfolio, which has outperformed the S&P and recorded >91% returns since its inception.
